Aqr Capital Management LLC Catalyst Biosciences, Inc. Transaction History

Aqr Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $98,026 - $127,434	-23,909 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.55 - $7.29 $2,429 - $3,892	-534 Reduced 2.18%	23,909 $151,000
Q3 2020 Nov 16, 2020	BUY	$4.22 - $6.04 $103,149 - $147,635	24,443 New	24,443 $105,000
Q2 2019 Aug 14, 2019	SELL	$7.08 - $10.6 $601,856 - $901,084	-85,008 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$7.67 - $9.96 $199,389 - $258,920	-25,996 Reduced 23.42%	85,008 $689,000
Q4 2018 Feb 14, 2019	BUY	$6.59 - $11.28 $113,578 - $194,410	17,235 Added 18.38%	111,004 $876,000
Q3 2018 Nov 15, 2018	BUY	$9.35 - $12.44 $659,352 - $877,256	70,519 Added 303.31%	93,769 $1.01 Million
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $211,807 - $671,460	23,250 New	23,250 $271,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.